Why is Nath Bio-Genes falling/rising?

As of 29-Jul, Nath Bio-Genes (India) Ltd is experiencing a price increase, currently at 182.25, reflecting a rise of 1.0 (0.55%). The stock has shown a trend reversal, gaining after three consecutive days of decline. Despite this uptick, the stock has underperformed significantly over the past year, with a return of -23.42%, and a -11.96% decline over the last month. The stock is currently trading at a discount compared to its peers, with a Price to Book Value of 0.5 and a Return on Equity of 6, indicating a very attractive valuation. However, the company has shown weak long-term fundamental strength, with a -0.69% CAGR growth in operating profits over the last five years, and a decrease in institutional investor participation, which may weigh on future performance.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has declined by -4.08% over the past week while the Sensex has only fallen by -1.03%. This consistent underperformance against the benchmark over the last three years highlights the challenges faced by Nath Bio-Genes. Although there has been a rise in investor participation, as indicated by a 19.7% increase in delivery volume, the overall sentiment remains cautious due to the company's flat results and declining institutional interest. Thus, while the stock has seen a slight increase today, the underlying fundamentals and market conditions suggest a challenging environment ahead.